Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

Presentation TVT 2023

Point: SAVR

Presenter: Keith Allen

June 09, 2023

Presentation TVT 2023

Position 1: SAVR With Root Enlargement

Presenter: Bo Yang

June 08, 2023

Presentation TVT 2023

Ascending Aorta Dilation & TAVR vs SAVR: When Should it Matter?

Presenter: Katherine Harrington

June 08, 2023

Presentation TVT 2023

Results From TAVR Explanation and Redo SAVR are Important Considerations: Updates and Evidence Gaps

Presenter: Basel Ramlawi

June 08, 2023

Presentation TVT 2023

What Do We Actually Know About Bioprosthetic Valve Durability (SAVR and TAVR)

Presenter: Danny Dvir

June 08, 2023

Presentation TVT 2022

Interpreting TAVR and SAVR PPM Studies: Effects on Clinical Outcomes and Practice?

Presenter: Howard C. Herrmann

June 09, 2022

Presentation TVT 2022

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Presenter: Janarthanan Sathananthan

June 08, 2022

Presentation TVT 2021

Valve-in-Valve TAVR vs Reoperative SAVR in Patients With Failed Aortic Bioprosthesis: Insight from Nationwide Readmission Database

Presenter: Ankur Kalra

July 22, 2021

Presentation TVT 2021

TAVR in TAVR in SAVR in a 26-Year-Old Girl

Presenter: Rikard Linder

July 21, 2021

Presentation TVT 2021

Hemodynamic Consideration of SAVR &ViV-TAVR

Presenter: Tsuyoshi Kaneko

July 21, 2021

Presentation TVT 2021

Prosthesis Patient Mismatch in TAVR vs SAVR: Much Ado About Nothing?

Presenter: Houman Khalili

July 21, 2021

Presentation TVT 2021

Post-procedural Hemodynamics: What to Make of Invasive & Echocardiographic Transvalvular Gradients?

Presenter: Amr Abbas

July 21, 2021

Presentation TVT 2021

Echocardiography & Aortic Stenosis Pre-TAVR: Pitfalls & Pearls

Presenter: Dee Dee Wang

July 21, 2021

Presentation TVT 2021

Comparative Analyses of PPM With SAVR and TAVR

Presenter: Neal Kleiman

July 20, 2021

Presentation TVT 2021

TAVR and SAVR “Sequencing”: Lifelong Management Journey of Severe AS

Presenter: Isaac George

July 20, 2021

Presentation TVT 2019

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

Presenter: Raj Makkar

June 13, 2019

Presentation TVT 2019

Do We Need a Randomized Trial of VIV vs. Redo SAVR for Failed Bioprosthetic Surgical Valves? The REPEAT Trial

Presenter: Vinayak Bapat

June 13, 2019

Presentation TVT 2017

A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability

Presenter: Martin B. Leon, Hendrik Treede

June 16, 2017

Presentation TVT 2017

A Model of TAVR (vs SAVR) Case Selection, Based Solely on Clinical and Anatomic Factors

Presenter: David J. Cohen, Jeffrey J. Popma, Martin B. Leon

June 16, 2017

Presentation TVT 2017

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

Presenter: A. Pieter Kappetein

June 16, 2017

Advertisement

Point: SAVR

Position 1: SAVR With Root Enlargement

Ascending Aorta Dilation & TAVR vs SAVR: When Should it Matter?

Results From TAVR Explanation and Redo SAVR are Important Considerations: Updates and Evidence Gaps

What Do We Actually Know About Bioprosthetic Valve Durability (SAVR and TAVR)

Interpreting TAVR and SAVR PPM Studies: Effects on Clinical Outcomes and Practice?

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Valve-in-Valve TAVR vs Reoperative SAVR in Patients With Failed Aortic Bioprosthesis: Insight from Nationwide Readmission Database

TAVR in TAVR in SAVR in a 26-Year-Old Girl

Hemodynamic Consideration of SAVR &ViV-TAVR

Prosthesis Patient Mismatch in TAVR vs SAVR: Much Ado About Nothing?

Post-procedural Hemodynamics: What to Make of Invasive & Echocardiographic Transvalvular Gradients?

Echocardiography & Aortic Stenosis Pre-TAVR: Pitfalls & Pearls

Comparative Analyses of PPM With SAVR and TAVR

TAVR and SAVR “Sequencing”: Lifelong Management Journey of Severe AS

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

Do We Need a Randomized Trial of VIV vs. Redo SAVR for Failed Bioprosthetic Surgical Valves? The REPEAT Trial

A Surgeons Viewpoint on SAVR vs TAVR Bioprosthetic Valve Durability

A Model of TAVR (vs SAVR) Case Selection, Based Solely on Clinical and Anatomic Factors

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content